FDA Investigator Stephanie E Hubbard

Stephanie E Hubbard has conducted inspections on 94 sites in 4 countries as of 30 Aug 2011. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
94
Last Inspection Date:
30 Aug 2011
Investigator Role:
FDA Investigator
Redica ID:
100001232
Countries of Inspections:
United States of America, Argentina, Germany, Poland
FDA Investigators that have inspected at least one site in common with Stephanie E Hubbard:
Abdur Rashid, Alexander M Kay, Amanda L Evanco, Ana L Kewes, Ann B Borromeo, Anne E Johnson, Babatunde D Babalola, Barbara D Wright, Barbara M Frazier, Barbara T Carmichael, Bonita S Chester, Brandy D Brown, Brenda Rivera, Brentley S Collins, Calvin Foulks, Carolanne Currier, Claudele S Razo, Claudette D Brooks, Cordelia J Brammer, Crystal A Harlan, D Ross Spears, PhD, Dana M Klimavicz, David T Glover, Davis, Dawn M Braswell, Dellarese L Herbert, Derek C Price, Edward Deberry, Fulton A Varner, Hai Lient Phung, Helen R Bester, Ibad U Khan, Igbinoba, Inga M Warr, Ingrid A Zambrana, Jawaid Hamid, Jeffrey D Sheppard, Jimmy O Buford, John D Lloyd, Johnetta F Walters, Joseph F Owens, Justin A Boyd, Karen A Coleman, Katrina B Mosley Sloan, Kenny R Robinson, Kimberly Cdelk Brooks, Kip J Hanks, Kunapuli T Madhusudhan, Lakisha N Morton, Lareese K Thomas, Latonya T Jiggetts, Leon L Crawley, Leslie W Gilbert, Lori A Gioia, Marian A Kainer, Mary A Millner, Mcbean, Melanie M Walker, Melanie W Pishnery, Miaja Umaedi, Myla D Chapman, Myoshi M Francis, Nancy A Bellamy, Nicole M Bell, Patricia F Hudson, Paul A Bonneau, Paul W Moy, Rashonda N Rucker, Rhonda Alexander, Robin N Goins, Rodney T Allnutt, Ronnie E Jackson, Sandra C Lawrence, Sayeeda Hdabe, Seneca D Toms, Sereen Gmorgan Murray, Sheri S Oliver, Tamika D Cathey, Tammara A Stephens, Trang N Cox, Vanessa E Coulter, Victoria L Palmer, Vincent M Williams, Xiomara Copeland

Stephanie E Hubbard's Documents

Publish Date Document Type Title
April, 2003 EIR Raymond E. Tidman, MD - EIR, 2003-04-29
December, 2000 FDA 483 Equi-Tox, Inc. - Form 483, 2000-12-07
May, 2000 EIR Simon, Stuart J., Md - EIR, 2000-05-04
June, 2002 EIR Mark R. Ling, M.D., Ph.D. - EIR, 2002-06-26
March, 2000 EIR Northeast Georgia Medical Center, Inc. IRB - EIR, 2000-03-01
December, 2000 EIR Equi-Tox, Inc. - EIR, 2000-12-07
May, 2001 FDA 483 Dornier Medtech America, Inc. - Form 483, 2001-05-15
November, 2006 FDA 483 Sambunaris, Angelo MD - Form 483, 2006-11-16
November, 2005 FDA 483 E. Clinton Lawrence, MD - Form 483, 2005-11-29
April, 2002 FDA 483 Saleh, Mansoor N. M.D. - Form 483, 2002-04-15
November, 2005 EIR E. Clinton Lawrence, MD - EIR, 2005-11-29
September, 2000 EIR Steven R. Shrum, M.D. - EIR, 2000-09-28
April, 2002 EIR Saleh, Mansoor N. M.D. - EIR, 2002-04-15
February, 2000 FDA 483 Ferguson, RObert C. M.D. - Form 483, 2000-02-25
April, 2002 FDA 483 Response Saleh, Mansoor N. M.D. - Form 483R, 2002-04-18
November, 2003 EIR LoBuglio, Albert F. M.D. - EIR, 2003-11-10
February, 2000 EIR Ferguson, RObert C. M.D. - EIR, 2000-02-25
May, 2000 EIR Alcon Research LLC - EIR, 2003-06-23
November, 2005 FDA 483 Response E. Clinton Lawrence, MD - Form 483R, 2006-01-23
May, 2001 EIR Dornier Medtech America, Inc. - EIR, 2001-05-15
April, 2004 FDA 483 Fredrick C. Robinson, M.D. - Form 483, 2004-04-30
February, 2002 FDA 483 Atlanta Gastroenterology Associates - Form 483, 2002-02-18
October, 2010 FDA 483 Alexander, Elmore - Form 483, 2010-10-20
December, 2000 EIR Robert A. Riesenberg, M.D. - EIR, 2000-12-13
December, 2000 FDA 483 Atlanta Center for Medical Research - Form 483, 2000-12-13
November, 2000 EIR Green, Arthuir D.O. - EIR, 2000-11-07
March, 2000 FDA 483 Northeast Georgia Medical Center, Inc. IRB - Form 483, 2000-03-01
April, 2003 FDA 483 Raymond E. Tidman, M.D./Riverbirch Research LLC - Form 483, 2003-04-29

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more